Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years

Purpose: Adaptive optics optical coherence tomography (AO-OCT) has the potential to transform how glaucoma progression is assessed by directly measuring loss of ganglion cells over time. Here, we used AO-OCT to measure ganglion cell layer (GCL) soma loss in glaucoma subjects over time intervals as short as 3 months. Methods: We recruited six glaucoma subjects with moderate-to-severe primary open-angle, low-tension, or pigmentary glaucoma (63.2 ± 3.4 years, mean ± SD) and two age-similar controls. AO-OCT volumes traversing arcuate defects were acquired at both multi-year (2-8 years, 3 subjects) and sub-year (3-12 months, all subjects) intervals. GCL soma count and layer thickness were measured in four to six subregions per subject to determine annualized loss rate (%/yr) across the defect. Clinical OCT thickness measurements were also acquired. Results: Annualized GCL soma loss rates in the 3 multi-year subjects were -1.8, -10.3, and -5.4%/yr, exceeding aging rates in controls by approximately 5 to 28 times. Loss was detectable in all subjects at 3- to 6-month intervals (-0.35 to -7.8%/yr). Soma density loss and GCL thinning rates were weakly correlated when the follow-up interval was under 1 year (glaucomatous: r = 0.32; healthy: r = 0.34). Variation in loss rate across the arcuate defect was significant over sub-year intervals, with the highest rates near the defect edge. Clinical OCT measurements did not exceed progression thresholds in any subject over sub-year intervals. Conclusions: AO-OCT can detect individual glaucomatous GCL soma loss over intervals as short as 3 months, at rates clearly distinguishable from age-related decline. Glaucomatous rates were subclinical by OCT and peaked within the arcuate defect.

Authors

Institutions

Publication Details

Journal
Investigative Ophthalmology & Visual Science
Published
2026-11-17
DOI
https://doi.org/10.1167/iovs.67.13.33
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years

Donald T. Miller, Marcel T. Bernucci, Qiuzhi Ji, William H. Swanson et al.
2 links
Investigative Ophthalmology & Visual Science
Glaucoma and retinal disorders
article

Tracking Retinal Ganglion Cell Soma Loss in Glaucoma Reveals Progression Over Months and Years

Donald T. Miller, Marcel T. Bernucci, Qiuzhi Ji, William H. Swanson, Brett J. King, Kristen Bowles-Johnson, Yan Liu, Kazuhiro Kurokawa, James A. Crowell, Matthew Keller
article en

Abstract

Purpose: Adaptive optics optical coherence tomography (AO-OCT) has the potential to transform how glaucoma progression is assessed by directly measuring loss of ganglion cells over time. Here, we used AO-OCT to measure ganglion cell layer (GCL) soma loss in glaucoma subjects over time intervals as short as 3 months. Methods: We recruited six glaucoma subjects with moderate-to-severe primary open-angle, low-tension, or pigmentary glaucoma (63.2 ± 3.4 years, mean ± SD) and two age-similar controls. AO-OCT volumes traversing arcuate defects were acquired at both multi-year (2-8 years, 3 subjects) and sub-year (3-12 months, all subjects) intervals. GCL soma count and layer thickness were measured in four to six subregions per subject to determine annualized loss rate (%/yr) across the defect. Clinical OCT thickness measurements were also acquired. Results: Annualized GCL soma loss rates in the 3 multi-year subjects were -1.8, -10.3, and -5.4%/yr, exceeding aging rates in controls by approximately 5 to 28 times. Loss was detectable in all subjects at 3- to 6-month intervals (-0.35 to -7.8%/yr). Soma density loss and GCL thinning rates were weakly correlated when the follow-up interval was under 1 year (glaucomatous: r = 0.32; healthy: r = 0.34). Variation in loss rate across the arcuate defect was significant over sub-year intervals, with the highest rates near the defect edge. Clinical OCT measurements did not exceed progression thresholds in any subject over sub-year intervals. Conclusions: AO-OCT can detect individual glaucomatous GCL soma loss over intervals as short as 3 months, at rates clearly distinguishable from age-related decline. Glaucomatous rates were subclinical by OCT and peaked within the arcuate defect.

Investigative Ophthalmology & Visual ScienceVol. 67(13)
Indiana University Bloomington (US), Indiana University (US)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon